Page 220 - Vitamin D and Cancer
P. 220

9  Molecular Biology of Vitamin D Metabolism and Skin Cancer    207

              phosphorylation with control HPK1A cells was detected with over expression of
            active MAPK kinase and these cells failed to drive reporter activity. The reverse
            was then tested by using the 1,25(OH) D  resistant HPK1A Ras cells expressing a
                                           2  3
            mutant RXR of serine to alanine at the relevant position. Indeed the restoration of
            reporter activity and the detection of serine phosphorylation confirmed that an acti-
            vated Ras/MAPK signaling pathway in tumor cells can cause the phosphorylation
            of the RXR, which in turn may interfere with 1,25(OH) D  transactivation mediated
                                                        2  3
            growth  inhibition.  Further  understanding  of  the  exact  mechanism  of  how  RXR
            phosphorylation can lead to the disturbance of its interaction with proteins required
            for 1,25(OH) D  transactivation, which could yield important ideas for chemopre-
                      2  3
            vention therapies.


            9.5.4   The Role of Vitamin D in Photoprotection


            The most well known consequence of UVB radiation is the appearance of apop-
            totic  or  sunburn  cells  [88].  Cellular  stresses  including  UV  irradiation  activates
            c-Jun NH2-terminal kinase (JNK) [74] and there is evidence that upregulation of
            stress  activated  protein  kinases  (SAPKs)  promotes  apoptosis  [158,  163].  The
            tumor suppressor gene, p53, can either induce cell cycle arrest by upregulating
            cyclin dependant kinase inhibitor P21 [144] or inducing apoptosis if the damage
            is extensive and cannot be repaired [37]. The interaction between JNK and p53,
            and the precise pathway of JNK mediated apoptosis and carcinogenesis is not yet
            fully elucidated. The interaction of p53 with JNK could conceivably prevent the
            interaction of p53 to the p21 promoter to inhibit cell cycle arrest and thus favors
            apoptosis [142]. It has been demonstrated that JNK2 knockout mice have a lower
            number of papillomas and malignant tumors induced by 12-O-tetradecanoylphor-
            bol-13-acetate compared to wild type mice, suggesting that JNK2 is critical in
            tumor promotion [27].
              De Haes et al. found that pretreating keratinocytes for 24 h prior to UVB radia-
            tion  with  pharmacological  dose  of  1,25(OH) D   (1  mM)  reduced  apoptosis  by
                                                  2  3
            55–70%. Moreover, a reduction of UVB stimulated JNK activation of more than
            30% was also found together with a 90% inhibition of mitochondrial cytochrome c
            release [33]. This can possibly be explained by the recent finding of the ability of
            p53 to protect cells against UV induced apoptosis via the binding and inactivation
            of  JNK  pathway,  which  is  responsible  for  the  induction  of  mitochondrial  death
            signaling [99].
              It has also been noted [33] that the culture conditions in terms of dose and pre-
            incubation time of 1,25(OH) D  were very similar to those used to conduct growth
                                   2  3
            inhibition experiments on proliferating keratinocytes [14, 139]. It is hypothesized
            that the observed accumulation of keratinocytes in the G  phase of these experi-
                                                           1
            ments may have protected the DNA from the genotoxic effects of UVB, as the
            unfolded structure of DNA in the S phase will render it more susceptible to UVB
            induced DNA damage [123]. This hypothesis is in agreement with the findings of
   215   216   217   218   219   220   221   222   223   224   225